Conjunctival melanoma in patients with xeroderma pigmentosum: a series of four cases.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
May 2020
Historique:
received: 06 09 2019
accepted: 31 12 2019
pubmed: 15 1 2020
medline: 27 3 2021
entrez: 15 1 2020
Statut: ppublish

Résumé

To study the demographic features, treatment, histopathology, and outcomes in patients of xeroderma pigmentosum (XP) with conjunctival melanoma. Retrospective case series. The median age at presentation was 18 years (range 9-30 years). There were three females and one male patient presenting with a median duration of symptoms of 3 months (range 1-60 months). The tumor was located in the bulbar conjunctiva in all 4 patients. All patients had corneal involvement by the tumor. The median tumor basal diameter was 7 mm (range 4-15 mm). Wide tumor excisional biopsy with alcohol keratoepithelectomy, cryotherapy to the free margins, and amniotic membrane grafting was done in three patients. One patient underwent orbital exenteration for extensive tumor. One patient also received adjuvant plaque brachytherapy for microscopic residual tumor. Over a median follow-up of 22 months (range 2-101 months), there were no recurrences, metastasis, or death. Conjunctival melanoma in XP is rare and manifests at a younger age.

Identifiants

pubmed: 31933024
doi: 10.1007/s10792-019-01279-2
pii: 10.1007/s10792-019-01279-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1143-1146

Auteurs

Varshitha Hemanth Vasanthapuram (VH)

Operation Eyesight Universal Institute for Eye Cancer (VHV, SK), L V Prasad Eye Institute, Hyderabad, 500034, India.

Swathi Kaliki (S)

Operation Eyesight Universal Institute for Eye Cancer (VHV, SK), L V Prasad Eye Institute, Hyderabad, 500034, India. kalikiswathi@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH